Skip to main content

Author: Customer Service

Kitron receives EUR 55 million defence order

(2025-12-10) Kitron has received an order with a value of EUR 55 million from a customer in the Defence/Aerospace market sector. “This order is yet another example of the strong demand we have reported in the defence sector, and it confirms our agility and ability to rapidly scale,” says Peter Nilsson, CEO of Kitron. Deliveries are set to take place in 2026. For further information, please contact:Peter Nilsson, President and CEO, tel. +47 948 40 850Hans Petter Thomassen, VP Nordics and North America tel. +47 91392360Email: investorrelations@kitron.com Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The group has operations located in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic,...

Continue reading

Karolinska Development’s portfolio company AnaCardio presents positive top-line data from the phase 2a study of its drug candidate AC01

STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has reported strong, positive results from the phase 2a clinical trial GOAL-HF1, evaluating the drug candidate AC01 in patients with heart failure and reduced ejection fraction (HFrEF). The study met its primary endpoint, demonstrating a favorable safety and tolerability profile, and showed encouraging, consistent efficacy signals paving the way for a rapid advancement to phase 2b. AnaCardio AB is a privately held Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure. The company has recently concluded a clinical phase 2a study with its lead asset, AC01, , demonstrating a favorable safety and tolerability profile, which was the study’s primary endpoint. While...

Continue reading

Viridien announces new seismic reimaging program over block 22 offshore Angola to support upcoming licensing round

Paris, France – December 10, 2025 Viridien has announced a new multi-client seismic reimaging program over Angola’s highly prospective offshore block 22 to support the country’s upcoming licensing round. The 4,300 sq km high-end data set will bring valuable insight into underexplored structures along the Atlantic Hinge zone, following the same trend as the proven Cameia and Golfinho fields. Fast-track results are scheduled for delivery in Q1 2026 and final products in Q3/Q4 2026. Viridien will reimage the block 22 data set with its latest proven proprietary technologies, including time-lag FWI, Q-FWI, Q-Kirchhoff and advanced deghosting and demultiple. This data will complement its 2,900 sq km of data over nearby block 20/11, giving operators access to a combined regional coverage of over 7,200 sq km of ultramodern broadband PSDM data...

Continue reading

Sampo plc’s share buybacks 9 December 2025

Sampo plc, stock exchange release, 10 December 2025 at 8:30 am EET Sampo plc’s share buybacks 9 December 2025 On 9 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  9,990 10.04 AQEU    111,762 10.04 CEUX  36,071 10.04 TQEX  102,332 10.04 XHELTOTAL 260,155 10.04  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

Fnac Darty announces full buy-in of UK pension scheme

Ivry-sur-Seine, France, 10 December 2025, 7h45 FNAC DARTY ANNOUNCES FULL BUY-IN OF UK PENSION SCHEME Fnac Darty today announces that it has reached an agreement with the Trustee of the Comet Pension Scheme in the UK to fully insure the Scheme’s liabilities through a £330 million full buy-in with Canada Life UK. The transaction secures the long-term benefits of all Scheme members by transferring the financial risk associated with future pension payments to a highly rated insurer. This marks a major de-risking milestone for Fnac Darty, providing greater cost certainty and strengthening its long-term financial position. The Scheme was part of Darty’s legacy UK operations and became part of the group following the acquisition of Darty in 2016. Under the terms of the agreement with the Trustee, this operation has no material impact on the Group’s...

Continue reading

The Magnum Ice Cream Company confirms inclusion in AEX index on Euronext Amsterdam

Amsterdam 10 December 2025 | The Magnum Ice Cream Company (TMICC; AEX: “MICC”), the world’s largest ice cream company, today confirmed its inclusion in the AEX Index on Euronext Amsterdam as of its first day of trading on 8 December. The announcement follows Euronext’s quarterly index review, which is based on criteria, including free-float and market capitalisation. The AEX Index comprises the 30 largest and most actively traded companies listed on Euronext Amsterdam and is the main index of the Dutch stock market. “As the global ice cream leader, headquartered in Amsterdam, The Netherlands – we are proud to be included alongside leading Dutch and international businesses as part of the AEX – Euronext Amsterdam’s premier index. As we begin life as a listed company, we look forward to engaging with investors and expanding the Ice Cream...

Continue reading

Amendment to battery cell supply agreement

(10 December 2025 – Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus (“the “Company”) on 18 April 2023 and 25 October 2024, where Hexagon Purus Systems USA LLC, a subsidiary of the Company, signed a multi-year agreement for the supply of lithium-ion battery cells and the subsequent amendment of its terms. Hexagon Purus Systems USA LLC has today entered into a second amendment to the supply agreement with its battery cell supplier. Under this amended agreement, the previously outstanding pre-payment obligation of USD 12.9 million is removed in full, while continued supply of battery cells to Hexagon Purus is ensured. Furthermore, any Inflation Reduction Act (IRA) incentives or credits that may arise from the supplier’s production of battery cells will accrue to the supplier. For more information: Mathias Meidell, Investor...

Continue reading

New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD

New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a high-risk CKD population with difficult-to-control hypertensionAllschwil, Switzerland – December 10, 2025Idorsia Ltd (SIX: IDIA) announced the publication of a new analysis from the landmark Phase 3 PRECISION study in Hypertension titled “Aprocitentan in Patients with Chronic Kidney Disease and Resistant Hypertension”.1 The analysis examined the efficacy and safety of aprocitentan (TRYVIO™/JERAYGO™) in patients with chronic kidney disease (CKD) and confirmed resistant hypertension – a population with very limited treatment options and high cardiovascular and renal risk. Aprocitentan, the first approved antihypertensive targeting...

Continue reading

Coop Pank AS results for November 2025

Coop Pank’s financial results in November 2025:In November, the number of the bank’s customers increased by 1,800 and number of active customers increased by 1,000. By the end of the month number of customers reached 225,800 and number of active customers reached 107,800. Over the year, customer base has grown by 10%. Volume of the bank’s customer deposits increased by 24 million euros and reached 1.97 billion euros by the end of the month. Deposits of corporate customers increased by 22 million euros and deposits of private customers increased by 11 million euros. The volume of deposits attracted from international platforms decreased by 9 million euros. Over the year, volume of bank deposits has grown by 138 million euros, i.e. 8%.   The bank’s loan portfolio increased by 28 million euros and reached 2.06 billion euros...

Continue reading

Aegon Capital Markets Day 2025 – The Next Frontier

Strategic highlights: Aegon announces ambition to become a leading US life insurance and retirement group Aegon to move its head office and legal seat to the US and be renamed Transamerica Inc. at completion of transition, which Aegon aims to conclude by January 1, 2028 Aegon Asset Management to focus on growing third-party revenues and improving efficiency Continued focus on profitable growth in Aegon’s International business Strategic review of Aegon UK, evaluating all options, including divestmentFinancial highlights:Achieving all financial targets for 2025 Further execution upon Aegon’s strategy to reduce capital employed in Financial Assets through a reinsurance transaction on part of its SGUL block, reducing mortality and policyholder behavior risk and capital employed by USD 0.3 billion. Negative impact on RBC ratio neutralized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.